Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.50
Delayed Data
As of 4:00pm ET
 -0.01 / -0.66%
Today’s Change
0.92
Today|||52-Week Range
1.68
+19.05%
Year-to-Date
No recent news for ArQule Inc.

Today’s Trading

Previous close1.51
Today’s open1.50
Day’s range1.49 - 1.52
Volume220,638
Average volume (3 months)259,162
Market cap$131.5M
Dividend yield--
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-18.18%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-58.10%
P/E ratioNM
Price/Sales18.65
Price/Book4.54

Competitors

 Today’s
change
Today’s
% change
MRNSMarinus Pharmaceutic...-0.47-5.98%
CEMIChembio Diagnostics ...-0.05-0.70%
ARLZAralez Pharmaceutica...-0.05-3.38%
DRNADicerna Pharmaceutic...+0.14+1.85%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateMarch 7, 2018
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.7M
Annual profit (last year)-$22.7M
Net profit margin-482.44%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President, Chief Operating Officer &
Secretary
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts